{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:47:58Z","timestamp":1790646478608,"version":"4.1.0"},"reference-count":62,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>The goal of biomarker testing, in the field of personalized medicine, is to guide treatments to achieve the best possible results for each patient. The accurate and reliable identification of everyone\u2019s genome variants is essential for the success of clinical genomics, employing third-generation sequencing. Different variant calling techniques have been used and recommended by both Oxford Nanopore Technologies (ONT) and Nanopore communities. A thorough examination of the variant callers might give critical guidance for third-generation sequencing-based clinical genomics. In this study, two reference genome sample datasets (NA12878) and (NA24385) and the set of high-confidence variant calls provided by the Genome in a Bottle (GIAB) were used to allow the evaluation of the performance of six variant calling tools, including Human-SNP-wf, Clair3, Clair, NanoCaller, Longshot, and Medaka, as an integral step in the in-house variant detection workflow. Out of the six variant callers understudy, Clair3 and Human-SNP-wf that has Clair3 incorporated into it achieved the highest performance rates in comparison to the other variant callers. Evaluation of the results for the tool was expressed in terms of Precision, Recall, and F1-score using Hap.py tools for the comparison. In conclusion, our findings give important insights for identifying accurate variants from third-generation sequencing of personal genomes using different variant detection tools available for long-read sequencing.<\/jats:p>","DOI":"10.3390\/genes13091583","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T23:35:57Z","timestamp":1662420957000},"page":"1583","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of the Available Variant Calling Tools for Oxford Nanopore Sequencing in Breast Cancer"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0714-1207","authenticated-orcid":false,"given":"Asmaa A.","family":"Helal","sequence":"first","affiliation":[{"name":"Department of Bioinformatics, HITS Solutions Co., Cairo 11765, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0650-0519","authenticated-orcid":false,"given":"Bishoy T.","family":"Saad","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, HITS Solutions Co., Cairo 11765, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina T.","family":"Saad","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, HITS Solutions Co., Cairo 11765, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal S.","family":"Mosaad","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, HITS Solutions Co., Cairo 11765, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7608-850X","authenticated-orcid":false,"given":"Khaled M.","family":"Aboshanab","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Organization of African Unity St., Cairo 11566, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5732\/cjc.012.10216","article-title":"Application of Next-Generation Sequencing in Clinical Oncology to Advance Personalized Treatment of Cancer","volume":"31","author":"Guan","year":"2012","journal-title":"Chin. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4174\/astr.2017.92.5.331","article-title":"Next-Generation Sequencing of BRCA1\/2 in Breast Cancer Patients: Potential Effects on Clinical Decision-Making Using Rapid, High-Accuracy Genetic Results","volume":"92","author":"Park","year":"2017","journal-title":"Ann. Surg. Treat. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.6004\/jnccn.2009.0070","article-title":"Breast Cancer Screening and Diagnosis","volume":"7","author":"Bevers","year":"2009","journal-title":"J. Nat. Comprehen. Cancer Netw."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nbt.4060","article-title":"Nanopore Sequencing and Assembly of a Human Genome with Ultra-Long Reads","volume":"36","author":"Jain","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1101\/gr.260497.119","article-title":"Comprehensive Analysis of Structural Variants in Breast Cancer Genomes Using Single-Molecule Sequencing","volume":"30","author":"Aganezov","year":"2020","journal-title":"Genome Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41587-019-0054-x","article-title":"Best Practices for Benchmarking Germline Small-Variant Calls in Human Genomes","volume":"37","author":"Krusche","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"928562","DOI":"10.1155\/2013\/928562","article-title":"A Comprehensive Focus on Global Spectrum of BRCA1 and BRCA2 Mutations in Breast Cancer","volume":"2013","author":"Karami","year":"2013","journal-title":"BioMed Res. Inter."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s42256-020-0167-4","article-title":"Exploring the Limit of Using a Deep Neural Network on Pileup Data for Germline Variant Calling","volume":"2","author":"Luo","year":"2020","journal-title":"Nat. Mach. Intell."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41467-019-09025-z","article-title":"Clairvoyante: A Multi-Task Convolutional Deep Neural Network for Variant Calling in Single Molecule Sequencing","volume":"10","author":"Luo","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/s41467-019-12493-y","article-title":"Longshot Enables Accurate Variant Calling in Diploid Genomes from Single-Molecule Long Read Sequencing","volume":"10","author":"Edge","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_11","unstructured":"(2022, August 10). GitHub\u2014Nanoporetech\/Medaka: Sequence Correction Provided by ONT Research. Available online: https:\/\/github.com\/nanoporetech\/medaka."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13059-021-02472-2","article-title":"NanoCaller for Accurate Detection of SNPs and Indels in Difficult-to-Map Regions from Long-Read Sequencing by Haplotype-Aware Deep Neural Networks","volume":"22","author":"Ahsan","year":"2021","journal-title":"Genome Biol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Luo, J., Ding, H., Shen, J., Zhai, H., Wu, Z., Yan, C., and Luo, H. (2021). BreakNet: Detecting deletions using long reads and a deep learning approach. BMC Bioinform., 22.","DOI":"10.1186\/s12859-021-04499-5"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","article-title":"Minimap2: Pairwise Alignment for Nucleotide Sequences","volume":"34","author":"Li","year":"2018","journal-title":"Bioinformatics"},{"key":"ref_15","unstructured":"Samtools\u00b7GitHub (2022, August 10). GitHub. Available online: https:\/\/github.com\/samtools\/."},{"key":"ref_16","unstructured":"(2022, August 10). GitHub\u2014Ryanlayer\/Bedtools. Available online: https:\/\/github.com\/ryanlayer\/bedtools."},{"key":"ref_17","unstructured":"(2022, August 10). GitHub\u2014Epi2me-Labs\/Wf-Human-Snp: Small Variant Calling for Human Samples. Available online: https:\/\/github.com\/epi2me-labs\/wf-human-snp."},{"key":"ref_18","unstructured":"(2022, August 10). SnpEff and SnpSift. Available online: http:\/\/pcingola.github.io\/SnpEff\/."},{"key":"ref_19","unstructured":"(2022, August 08). ClinVar, Available online: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/."},{"key":"ref_20","unstructured":"(2022, August 08). Home\u2014MedGen\u2014NCBI, Available online: https:\/\/www.ncbi.nlm.nih.gov\/medgen\/."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/GIM.0b013e3182217a3a","article-title":"American College of Medical Genetics Standards and Guidelines for Interpretation and Reporting of Postnatal Constitutional Copy Number Variants","volume":"13","author":"Kearney","year":"2011","journal-title":"Genet. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence Variant Classification and Reporting: Recommendations for Improving the Interpretation of Cancer Susceptibility Genetic Test Results","volume":"29","author":"Plon","year":"2008","journal-title":"Hum. Mutat."},{"key":"ref_24","unstructured":"(2022, August 10). GitHub\u2014Illumina\/Hap.Py: Haplotype VCF Comparison Tools. Available online: https:\/\/github.com\/Illumina\/hap.py."},{"key":"ref_25","unstructured":"(2022, August 08). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries\u2014Sung\u20142021\u2014CA: A Cancer Journal for Clinicians\u2014Wiley Online Library. Available online: https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.3322\/caac.21660."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11523-021-00796-4","article-title":"An Overview of PARP Inhibitors for the Treatment of Breast Cancer","volume":"16","author":"Cortesi","year":"2021","journal-title":"Target. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"212540","DOI":"10.7573\/dic.212540","article-title":"Advances in the Use of PARP Inhibitor Therapy for Breast Cancer","volume":"7","author":"McCann","year":"2018","journal-title":"Drugs Context"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41523-022-00411-3","article-title":"PARP Inhibition in Breast Cancer: Progress Made and Future Hopes","volume":"8","author":"Tung","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12032-022-01749-1","article-title":"Molecular Perspective on Targeted Therapy in Breast Cancer: A Review of Current Status","volume":"39","year":"2022","journal-title":"Med. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.25122\/jml-2020-0132","article-title":"The Role of Novel Poly (ADP-Ribose) Inhibitors in the Treatment of Locally Advanced and Metastatic Her-2\/Neu Negative Breast Cancer with Inherited Germline BRCA1\/2 Mutations. A Review of the Literature","volume":"14","author":"Pop","year":"2021","journal-title":"J. Med. Life"},{"key":"ref_31","first-page":"4363","article-title":"Efficacy and Safety of PARP Inhibitors in Advanced or Metastatic Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_32","first-page":"CD011395","article-title":"PARP (Poly ADP-Ribose Polymerase) Inhibitors for Locally Advanced or Metastatic Breast Cancer","volume":"2021","author":"Taylor","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early Breast Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Pepe, F., Pisapia, P., Russo, G., Nacchio, M., Pallante, P., Vigliar, E., De Angelis, C., Insabato, L., Bellevicine, C., and De Placido, S. (2021). BRCA1\/2 NGS Somatic Testing in Clinical Practice: A Short Report. Genes, 12.","DOI":"10.3390\/genes12121917"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cca.2018.02.012","article-title":"A Comprehensive BRCA1\/2 NGS Pipeline for an Immediate Copy Number Variation (CNV) Detection in Breast and Ovarian Cancer Molecular Diagnosis","volume":"480","author":"Concolino","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/jclinpath-2019-206127","article-title":"Next-Generation Sequencing-Based BRCA Testing on Cytological Specimens from Ovarian Cancer Ascites Reveals High Concordance with Tumour Tissue Analysis","volume":"73","author":"Fumagalli","year":"2020","journal-title":"J. Clin. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/jmedgenet-2021-108238","article-title":"Practice Guidelines for BRCA1\/2 Tumour Testing in Ovarian Cancer","volume":"59","author":"Grafodatskaya","year":"2022","journal-title":"J. Med. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jmoldx.2014.11.004","article-title":"Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and\/or Ovarian Cancer","volume":"17","author":"Trujillano","year":"2015","journal-title":"J. Mol. Diagn."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41525-020-0126-3","article-title":"Sequencing Technology Status of BRCA1\/2 Testing in Latin American Countries","volume":"5","author":"Solano","year":"2020","journal-title":"NPJ Genom. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00404-020-05881-z","article-title":"NGS-Guided Precision Oncology in Metastatic Breast and Gynecological Cancer: First Experiences at the CCC Munich LMU","volume":"303","author":"Sultova","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10459","DOI":"10.1038\/s41598-020-67393-9","article-title":"Real World Data Analysis of next Generation Sequencing and Protein Expression in Metastatic Breast Cancer Patients","volume":"10","author":"Hempel","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1200\/JGO.2019.5.suppl.34","article-title":"Adoption and Utilization of NGS-Based Molecular Profiling in Community-Based Oncology Practices: Insights from Sarah Cannon","volume":"5","author":"Schlauch","year":"2019","journal-title":"J. Glob. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1200\/PO.20.00469","article-title":"Next-Generation Sequencing of Patients With Breast Cancer in Community Oncology Clinics","volume":"5","author":"Sturgill","year":"2021","journal-title":"JCO Precis. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Eltokhy, M.A., Saad, B.T., Eltayeb, W.N., El-Ansary, M.R., Aboshanab, K.M., and Ashour, M.S.E. (2021). A Metagenomic Nanopore Sequence Analysis Combined with Conventional Screening and Spectroscopic Methods for Deciphering the Antimicrobial Metabolites Produced by Alcaligenes faecalis Soil Isolate MZ921504. Antibiotics, 10.","DOI":"10.3390\/antibiotics10111382"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1038\/s41598-018-30330-y","article-title":"Design and MinION Testing of a Nanopore Targeted Gene Sequencing Panel for Chronic Lymphocytic Leukemia","volume":"8","author":"Orsini","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yexmp.2017.06.007","article-title":"Mutational Analysis in BCR-ABL1 Positive Leukemia by Deep Sequencing Based on Nanopore MinION Technology","volume":"103","author":"Minervini","year":"2017","journal-title":"Exp. Mol. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13000-016-0550-y","article-title":"TP53 Gene Mutation Analysis in Chronic Lymphocytic Leukemia by Nanopore MinION Sequencing","volume":"11","author":"Minervini","year":"2016","journal-title":"Diagn. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fgene.2020.00076","article-title":"Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities","volume":"11","author":"Minervini","year":"2020","journal-title":"Front. Genet."},{"key":"ref_49","unstructured":"(2022, August 10). Index of \/Giab\/Ftp\/Data\/NA12878\/Ultralong_OxfordNanopore. Available online: https:\/\/github.com\/genome-in-a-bottle\/giab_data_indexes."},{"key":"ref_50","unstructured":"(2022, August 10). Index of \/Giab\/Ftp\/Data\/AshkenazimTrio\/HG002_NA24385_son\/Ultralong_OxfordNanopore\/Guppy-V3.2.4_2020-01-22. Available online: https:\/\/github.com\/genome-in-a-bottle\/giab_data_indexes\/blob\/master\/AshkenazimTrio\/sequence.index.AJtrio_UCSC_ONT_UL_guppy-V3.2.4_2020-01-22."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"100129","DOI":"10.1016\/j.xgen.2022.100129","article-title":"PrecisionFDA Truth Challenge V2: Calling variants from short and long reads in difficult-to-map regions","volume":"11","author":"Olson","year":"2022","journal-title":"Cell Genom."},{"key":"ref_52","unstructured":"(2022, August 10). Global Alliance for Genomics and Health\u00b7GitHub. Available online: https:\/\/github.com\/ga4gh."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1101\/gr.213462.116","article-title":"HapCUT2: Robust and accurate haplotype assembly for diverse sequencing technologies","volume":"27","author":"Edge","year":"2017","journal-title":"Genome Res."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Martin, M., Patterson, M., Garg, S., Fischer, S.O., Pisanti, N., Klau, G.W., Sch\u00f6enhuth, A., and Marschall, T. (2016). WhatsHap: Fast and Accurate Read-Based Phasing. bioRxiv, 085050. Available online: https:\/\/pub.uni-bielefeld.de\/record\/2941794.","DOI":"10.1101\/085050"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41592-021-01299-w","article-title":"Haplotype-Aware Variant Calling with PEPPER-Margin-DeepVariant Enables High Accuracy in Nanopore Long-Reads","volume":"18","author":"Shafin","year":"2021","journal-title":"Nat. Methods"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Barbitoff, Y.A., Abasov, R., Tvorogova, V.E., Glotov, A.S., and Predeus, A.V. (2022). Systematic Benchmark of State-of-the-Art Variant Calling Pipelines Identifies Major Factors Affecting Accuracy of Coding Sequence Variant Discovery. BMC Genom., 23.","DOI":"10.1186\/s12864-022-08365-3"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13073-020-00791-w","article-title":"Best Practices for Variant Calling in Clinical Sequencing","volume":"12","author":"Koboldt","year":"2020","journal-title":"Genome Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"17851","DOI":"10.1038\/s41598-018-36177-7","article-title":"Comparison of Three Variant Callers for Human Whole Genome Sequencing","volume":"8","author":"Supernat","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_59","unstructured":"(2022, August 08). GitHub\u2014Jts\/Nanopolish: Signal-Level Algorithms for MinION Data. Available online: https:\/\/github.com\/jts\/nanopolish."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jmoldx.2018.06.003","article-title":"Benchmarking of Amplicon-Based Next-Generation Sequencing Panels Combined with Bioinformatics Solutions for Germline BRCA1 and BRCA2 Alteration Detection","volume":"20","author":"Vendrell","year":"2018","journal-title":"J. Mol. Diagn."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ejhg.2012.270","article-title":"Next-Generation Sequencing Meets Genetic Diagnostics: Development of a Comprehensive Workflow for the Analysis of BRCA1 and BRCA2 Genes","volume":"21","author":"Tornero","year":"2013","journal-title":"Eur. J. Human Genet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e23524","DOI":"10.1002\/jcla.23524","article-title":"Performance Evaluation of an Amplicon-based Next-generation Sequencing Panel for BRCA1 and BRCA2 Variant Detection","volume":"34","author":"Park","year":"2020","journal-title":"J. Clin. Lab. Anal."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/9\/1583\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:22:53Z","timestamp":1760142173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/9\/1583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,3]]},"references-count":62,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["genes13091583"],"URL":"https:\/\/doi.org\/10.3390\/genes13091583","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,3]]}}}